A Study to Assess AFM13 in Patients With Hodgkin Lymphoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Affimed Therapeutics AG.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Affimed Therapeutics AG
Information provided by (Responsible Party):
Affimed Therapeutics AG
ClinicalTrials.gov Identifier:
NCT01221571
First received: October 5, 2010
Last updated: June 15, 2012
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2012 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
No publications provided by Affimed Therapeutics AG
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):